Dacenon, Mary Jane C.

HRN: 26-78-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2025
CEFTRIAXONE 1G (VIAL)
07/10/2025
07/17/2025
IV
2G
Od
Urosepsis Sec To Complicated Uti
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: